Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

iodine I 131 chimeric monoclonal antibody G-250

A radioimmunoconjugate comprised of the chimeric monoclonal antibody G-250 conjugated with iodine I 131 with potential antineoplastic activity. The antibody moiety of iodine I 131 chimeric monoclonal antibody G-250 binds to G-250, a renal-cell carcinoma-associated antigen, delivering cytotoxic iodine I 131 specifically to renal cell carcinoma cells that express G-250.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	I 131 Monoclonal Antibody G-250 iodine I 131 MOAB G-250 iodine I 131 monoclonal antibody G-250
Abbreviation:	iodine I 131 MOAB G250

iodine I 131 chimeric monoclonal antibody G-250

Search NCI's Drug Dictionary